lobal professional services firm, ZS elevates Pratap Khedkar to the position of CEO (Chief Executive Officer), effective immediately. Before being appointed as the CEO, Pratap was head of the ZS’s global biopharmaceuticals and healthcare ecosystem disciplines. He replaces Chris Wright who shared his excitement to hand over the baton to Pratap.
"Pratap is assuming this role at ZS during an exciting period of development and change,'' said Chris Wright, former CEO, ZS. “The firms we work with are increasingly turning to us to recognize, advise, and adapt to the next significant upheavals in their respective industries. I'm optimistic that, with Pratap's guidance, the finest days at ZS are yet ahead of us. "
“Chris has done a tremendous job during his tenure as CEO, and I’ll be leaning on his knowledge and guidance in the months and years ahead,” added Pratap. He said, “His greatest legacy is preserving the culture that our founders worked so hard to create. His emphasis on continually investing in our people has ‘kept the magic alive,’ as he’s been known to say.”
As principal emeritus, Chris will be linked with ZS for the next five years, focusing on his most passionate initiatives. On the other hand, Pratap brings in 21 years of experience with ZS. He has led the firm’s global pharmaceuticals and biotechnology practice for nearly a decade, driving growth and market penetration across both established and emerging companies. While heading up the firm’s advanced data science group, he and 250 data scientists helped integrate AI-enabled solutions across many business areas. He’s recently turned his attention to expanding the firm’s healthcare expertise to help clients establish deeper relationships and more effective partnerships across the healthcare ecosystem to improve health outcomes, emphasize a better patient experience and address health disparities.